Vertex Pharmaceuticals Profile



Odds of Distress

Check how we calculate scores
Equity ratings for Vertex Pharmaceuticals Incorpor are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 24, 2019 and ending today September 22, 2019. Click here to learn more.

Vertex Pharmaceuticals Summary

Vertex Pharmaceuticals Incorpor (VRTX) is traded on BATS Exchange in USA and employs 2,500 people. The company currently falls under 'Large-Cap' category with current market capitalization of 45.64B. Vertex Pharmaceuticals conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 257.04M outstanding shares of which 4.23M shares are at this time shorted by private and institutional investors with about 3.11 trading days to cover. VERTEX PHARMACEUT currently holds about 3.95B in cash with 1.1B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.37.
Check Vertex Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Vertex Pharmaceuticals Target Price Odds Analysis

Odds Below 176.14HorizonTargetOdds Above 176.14
34.00%30 days 176.14 65.61%
Based on normal probability distribution, the odds of Vertex Pharmaceuticals to move above current price in 30 days from now is about 65.61% (This Vertex Pharmaceuticals Incorpor probability density function shows the probability of Vertex Pharmaceuticals Stock to fall within a particular range of prices over 30 days) .

Vertex Pharmaceuticals Top Holders

Vertex Pharmaceuticals Incorpor Income Statement Over Time

Consolidated Income    Cost of Revenue    Earning Before Interest and Taxes EBIT    

Vertex Pharmaceuticals Key Fundamentals

Vertex Pharmaceuticals Against Markets

Vertex Pharmaceuticals Vital Trading Data

Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company was founded in 1989 and is headquartered in Boston, Massachusetts. Vertex Pharmaceuticals operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 2500 people. more
NameVertex Pharmaceuticals Incorpor
ChairmanJoshua BogerView All
Thematic Classification
Currently Active Investing Idea
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
RegionNorth America
Business Address50 Northern Avenue
Foreign Associates
ExchangeBATS Exchange
CIK Number0000875320
Phone617 341 6100
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestAugust 15, 2019

Vertex Pharmaceuticals Corporate Directors

William Young Independent Director
Alan Garber Independent Director
Margaret McGlynn Independent Director
Also please take a look at World Market Map. Please also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.